ANTICOAGULANTS AND THROMBOLYTICS - RISKS AND BENEFITS

被引:8
|
作者
GUIDRY, JR
RASCHKE, RA
MORKUNAS, AR
机构
关键词
D O I
10.1016/S0749-0704(18)30295-1
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:533 / 554
页数:22
相关论文
共 50 条
  • [41] Should patients treated with direct oral anticoagulants receive intravenous thrombolytics for acute ischaemic stroke?
    Khan, Faizan
    Meinel, Thomas
    Lun, Ronda
    Yu, Amy Y. X.
    Campbell, Bruce C. V.
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [42] Benefits and risks of reboxetine
    Hailer, Sarah
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2011, 61 (01) : 1 - 1
  • [43] CULTURAL BENEFITS AND RISKS
    Calamandrei, Silvia
    PONTE, 2011, 67 (09) : 87 - 91
  • [44] Tigecycline: benefits and risks
    Cai, Yun
    Wang, Rui
    LANCET INFECTIOUS DISEASES, 2011, 11 (11): : 804 - 805
  • [45] SACCHARIN - RISKS AND BENEFITS
    COHEN, BL
    NATURE, 1978, 273 (5665) : 704 - 704
  • [46] Risks and benefits of DDT
    Ross, G
    LANCET, 2005, 366 (9499): : 1771 - 1772
  • [47] Xenotransplantation: Benefits and risks
    Chapman, L
    EMERGING INFECTIOUS DISEASES, 2001, 7 (03) : 545 - 545
  • [48] Benefits and risks of reboxetine
    Hailer, Sarah
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2011, 79 (01) : 1 - 1
  • [49] Risks and benefits of bisphosphonates
    Coleman, R. E.
    BRITISH JOURNAL OF CANCER, 2008, 98 (11) : 1736 - 1740
  • [50] Weighing benefits and risks
    Isobel Barry
    Nature Reviews Cancer, 2008, 8 (7) : 484 - 484